The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes

Summary

The purpose of this study is to conduct an interventional, one year, randomized, double blind, placebo-controlled trial with Liraglutide in patients with type 2 diabetes (diabetes duration of \>6 months and \<10 years, HbA1c \<10%) to evaluate its effects on the peripheral autonomic nervous system, as well as inflammatory markers, and measures of oxidative and nitrosative stress.

Timeline

Start

2016-05

Primary completion

2020-04

Completion

2020-08

Drugs

Indications